BridgeMD
New treatment option for Pancreatic Steatosis
Official title Study for the Identification of a Score to Assess Intrapancreatic Fat Through Eco-Elastography and Its Correlation With Metabolic Syndrome and Insulin-Secreting Cells.
ClinicalTrials.gov ID: NCT06801769
What this study is testing
- What it's testing
- \ \ Brief Summary of the SPES Clinical Study\ \ The SPES clinical study aims to evaluate the relationship between pancreatic fat accumulation (pancreatic steatosis) and metabolic health. Pancreatic steatosis has been linked to conditions like type 2 diabetes (T2D) and metabolic syndrome, but the underlying mechanisms and its impact on beta-cell function remain poorly understood.
- Time commitment: about 24 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age between 18 and 80 years
- HbA1c \<10% or fasting glucose \<250 mg/dL
- Ability to understand and provide informed consent regarding the procedures, data collection, and analysis.
You likely can't join if
- Age \ 80 years
- History of diabetes treated with insulin
- HbA1c \>10% or fasting glucose \>250 mg/dL
- Pancreatic diseases (solid tumors/secretory NETs/cystic fibrosis; non-secretory NETs and IPMN may be included)
- Previous pancreatic surgery
- Moderate anemia (Hb \<10 mg/dL)
See the full eligibility criteria
- Age between 18 and 80 years
- HbA1c \<10% or fasting glucose \<250 mg/dL
- Ability to understand and provide informed consent regarding the procedures, data collection, and analysis.
- Age \ 80 years
- History of diabetes treated with insulin
- HbA1c \>10% or fasting glucose \>250 mg/dL
- Pancreatic diseases (solid tumors/secretory NETs/cystic fibrosis; non-secretory NETs and IPMN may be included)
- Previous pancreatic surgery
- Moderate anemia (Hb \<10 mg/dL)
- Severe liver failure (Child-Pugh C)
- Non-metabolic causes of NAPLD (e.g., corticosteroid therapy, antiretrovirals, gemcitabine, octreotide, history of hemochromatosis, malnutrition, HBV/HIV infections)
- Alcohol abuse (\>30 g/day of ethanol)
- Pregnancy and breastfeeding
- Inability to adequately understand informed consent and study procedures
The study team makes the final eligibility decision.
Where it's taking place
- Rome, Lazio, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 24 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rome, Lazio, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.